The future of cytotoxic therapy: selective cytotoxicity based on biology is the key

por de Bono, Johann S, Tolcher, Anthony W, Rowinsky, Eric K
Publicado 2003

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma

por Rowinsky, Eric K., Paner, Agne, Berdeja, Jesus G., Paba-Prada, Claudia, Venugopal, Parameswaran, Porkka, Kimmo, Gullbo, Joachim, Linder, Stig, Loskog, Angelica, Richardson, Paul G., Landgren, Ola
Publicado 2020